Abstract:We aimed to elucidate the role of miR-139 in the progression of non-small cell lung cancer (NSCLC) and its underlying mechanisms. Tumor tissues and paracancerous tissues were collected to obtain NSCLC cells and normal pulmonary epithelial cells, respectively. The expression of miR-139 in tissues and cells were determined via real-time quantitative PCR. The NSCLC cells were transfected with miR-139 inhibitor, siRNA-NC, miR-139 mimics, or vectors, respectively, followed by expression measurement of miR-139 via PCR. Colony formation and CCK-8 assays were employed to assess the cellular proliferation, along with transwell experiment for investigating the tendency of cancer cells in invasion and metastasis. The expression levels of proteins were semi-quantified via Western Blot analysis, including proteins involved in the epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway and those related to epithelial-mesenchymal transition (EMT). For rescue experiments, an EGFR agonist was applied to transfect cells, followed by the detection of potentials of cancer cells in proliferation and invasion along with the expression determination of the proteins involved. Eventually, mouse xenograft models were established using cells transfected with miR-139 inhibitor or siRNA-NC, respectively, of which the tumor development was monitored and the expression of EGFR in the tumor tissues of the mouse xenograft models was detected via immunohistochemical staining. A significant increase of miR-139 was detected in NSCLC tissues, of which the elevation was related to the tumor size, malignancy, and poor prognosis. Compared with cells in the control group. miR-139 inhibition enhanced the proliferation of NSCLC cells both in vivo and in vitro, which was accompanied by the suppressed expression of proteins related to the EMT process, along with the enhanced potentials cell invasion and migration. Additionally, miR-139 modulated EGFR expression and activated its signal transduction in EGFR/MEK/ERK pathway to exert its carcinogenic function. MiRNA-139 may facilitate NSCLC progression via modulating the EGFR/MEK/ERK signal-transduction pathway.

EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation

DRAM1 Plays a Tumor Suppressor Role in NSCLC Cells by Promoting Lysosomal Degradation of EGFR

MicroRNA-34a/EGFR Axis Plays Pivotal Roles in Lung Tumorigenesis

LINC01207 Promotes the Progression of Non-Small Cell Lung Cancer Via Regulating ARHGAP11A by Sponging Mir-525-5p

Long Non-Coding RNA DLGAP1-AS1 Modulates the Development of Non-Small-cell Lung Cancer Via the Microrna-193A-5p/dtl Axis

Long Non-Coding MELTF Antisense RNA 1 Promotes and Prognosis the Progression of Non-Small Cell Lung Cancer by Targeting Mir-1299

A Promising New Cancer Marker: Long Noncoding RNA EGFR-AS1

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Microarray Expression Profile of Long Non-Coding Rnas in Egfr-Tkis Resistance of Human Non-Small Cell Lung Cancer

The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.

LncRNA KTN1-AS1 Drives Tumor Progression in Non-Small Cell Lung Cancer through microRNA-153-3p/KLF5 Axis

Long Non-Coding RNA SLCO4A1-AS1 Drives the Progression of Non-Small-cell Lung Cancer by Modulating Mir-223-3p/ikkα/nf-κb Signaling.

Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis

Long Non-Coding RNA NCK1-AS1 Promotes the Proliferation, Migration and Invasion of Non-Small Cell Lung Cancer Cells by Acting As a Cerna of Mir-137.

Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR‑145 through the ERK1/2 in non-small cell lung cancer.

MicroRNA-139 Facilitates Non-Small Cell Lung Cancer Progression Via Modulating the Epidermal Growth Factor Receptor (Egfr)/mitogen-Activated Protein Kinase (mek)/extracellular Signal-Regulated Kinase (ERK) Signaling Pathway

Long Non-Coding RNA FGD5-AS1 Promotes Non-Small Cell Lung Cancer Cell Proliferation Through Sponging Hsa-Mir-107 to Up-Regulate FGFRL1

Silencing lncRNA‐DARS‐AS1 suppresses nonsmall cell lung cancer progression by stimulating miR‐302a‐3p to inhibit ACAT1 expression

Retracted: SLCO4A1‐AS1 Promotes Cell Growth and Induces Resistance in Lung Adenocarcinoma by Modulating Mir‐4701‐5p/nfe2l1 Axis to Activate WNT Pathway

AZIN1-AS1, A Novel Oncogenic LncRNA, Promotes the Progression of Non-Small Cell Lung Cancer by Regulating MiR-513b-5p and DUSP11

Down-regulation of MBNL1-AS1 Contributes to Tumorigenesis of NSCLC Via Sponging Mir-135A-5p